• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin.

作者信息

Machka K, Röbl M, Braveny I

出版信息

Eur J Clin Microbiol. 1986 Feb;5(1):115-8. doi: 10.1007/BF02013480.

DOI:10.1007/BF02013480
PMID:3084240
Abstract

The serum bactericidal activities of ceftriaxone, netilmicin, piperacillin and the combinations of ceftriaxone with each of the two other antibiotics were compared 1, 4 and 24 h after i.v. infusion in six volunteers. One hundred and one clinical isolates were used, including Staphylococcus aureus, Pseudomonas aeruginosa and various Enterobacteriaceae. The highest bactericidal titers were found against the Enterobacteriaceae, geometric means of 1:741 and 1:851 being obtained for ceftriaxone/netilmicin and ceftriaxone/piperacillin respectively. Against Staphylococcus aureus the geometric mean bactericidal titers of ceftriaxone/piperacillin (1:105) were markedly higher than ceftriaxone/netilmicin (1:35). Low bactericidal activity was exhibited by all drugs and combinations tested against Pseudomonas aeruginosa; a geometric mean bactericidal titer of 1:4.6 was achieved. The serum bactericidal activity of the double beta-lactam combinations was found to be at least equal to that of the combination containing a cephalosporin and an aminoglycoside.

摘要

相似文献

1
Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin.
Eur J Clin Microbiol. 1986 Feb;5(1):115-8. doi: 10.1007/BF02013480.
2
Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.头孢曲松-哌拉西林与头孢曲松-奈替米星的比较协同活性
Eur J Clin Microbiol. 1983 Oct;2(5):496-500. doi: 10.1007/BF02013915.
3
Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin.奈替米星-哌拉西林与庆大霉素-哌拉西林的比较协同活性
Eur J Clin Microbiol. 1982 Aug;1(4):238-42. doi: 10.1007/BF02019715.
4
Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.
Eur J Clin Microbiol. 1986 Feb;5(1):119-23. doi: 10.1007/BF02013481.
5
Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.哌拉西林/他唑巴坦对金黄色葡萄球菌、对哌拉西林敏感和耐药的大肠埃希菌以及铜绿假单胞菌的血清杀菌活性。
Chemotherapy. 2004 Apr;50(1):27-30. doi: 10.1159/000077281.
6
In vitro studies of the synergism of piperacillin and netilmicin against blood culture isolates.
Chemotherapy. 1986;32(1):68-74. doi: 10.1159/000238390.
7
The in vitro activity of netilmicin against 357 clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.奈替米星对357株临床分离的肠杆菌科细菌、铜绿假单胞菌和金黄色葡萄球菌的体外活性。
Scand J Infect Dis Suppl. 1980;Suppl 23:30-3.
8
Susceptibility of 327 clinical isolates to netilmicin.327株临床分离菌对奈替米星的敏感性
J Int Med Res. 1978;6(5):409-13. doi: 10.1177/030006057800600511.
9
[In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].哌拉西林-他唑巴坦联合奈替米星或阿米卡星对耐阿莫西林肠杆菌科细菌的体外抗菌活性
Pathol Biol (Paris). 1995 Mar;43(3):208-14.
10
In vitro synergism of ceftriaxone combined with aminoglycosides against Pseudomonas aeruginosa.头孢曲松与氨基糖苷类药物联合对铜绿假单胞菌的体外协同作用。
Diagn Microbiol Infect Dis. 1994 May;19(1):39-46. doi: 10.1016/0732-8893(94)90049-3.

引用本文的文献

1
Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.环丙沙星和氧氟沙星在志愿者体内的血清杀菌活性。
Eur J Clin Microbiol. 1987 Feb;6(1):59-62. doi: 10.1007/BF02097195.
2
Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.头孢曲松。对其抗菌活性和药代动力学特性的重新评估,以及关于其治疗用途的最新情况,特别提及每日一次给药。
Drugs. 1988 Jun;35(6):604-45. doi: 10.2165/00003495-198835060-00002.
3
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

本文引用的文献

1
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life.头孢曲松(Rocephin)的药代动力学,一种具有超长生物半衰期的高活性新型头孢菌素。
Chemotherapy. 1981;27 Suppl 1:42-6. doi: 10.1159/000238028.
2
Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria.用于革兰氏阴性菌和革兰氏阳性菌抗生素敏感性测试的Micur微量稀释系统评估。
Eur J Clin Microbiol. 1982 Dec;1(6):361-6. doi: 10.1007/BF02019935.
3
Association between serum inhibitory and bactericidal concentrations and therapeutic outcome in bacterial endocarditis.
奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.
Am J Med. 1982 Aug;73(2):260-7. doi: 10.1016/0002-9343(82)90188-7.
4
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.头孢曲松(Ro 13 - 9904)的抗菌活性,一种对β-内酰胺酶稳定的头孢菌素。
Antimicrob Agents Chemother. 1981 Mar;19(3):414-23. doi: 10.1128/AAC.19.3.414.
5
Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.Ro 13-9904,一种长效广谱头孢菌素:体外和体内研究
Antimicrob Agents Chemother. 1980 Dec;18(6):913-21. doi: 10.1128/AAC.18.6.913.
6
Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli.β-内酰胺类与妥布霉素联合用药对铜绿假单胞菌和多重耐药革兰氏阴性肠道杆菌的体外比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):1003-6. doi: 10.1128/AAC.21.6.1003.
7
In vitro evaluation of Ro 13-9904.Ro 13-9904的体外评估
Antimicrob Agents Chemother. 1980 Oct;18(4):574-8. doi: 10.1128/AAC.18.4.574.
8
Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia.粒细胞减少和非粒细胞减少患者革兰氏阴性杆菌菌血症中血清杀菌活性的意义
Am J Med. 1984 Mar;76(3):429-35. doi: 10.1016/0002-9343(84)90662-4.
9
Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients.在发热性粒细胞缺乏症患者中,头孢氧哌唑钠加哌拉西林与头孢氧哌唑钠加丁胺卡那霉素的对比研究
Am J Med. 1984 Sep;77(3):442-50. doi: 10.1016/0002-9343(84)90100-1.
10
Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.头孢他啶在血清中的杀菌活性与替卡西林联合阿米卡星的杀菌活性比较。
Antimicrob Agents Chemother. 1984 Sep;26(3):339-42. doi: 10.1128/AAC.26.3.339.